H.R. 3082 · 119th Congress (2025–2027)
Evidence-Based Drug Policy Act of 2025
To repeal section 704(b)(12) of the Office of National Drug Control Policy Reauthorization Act of 1998, and for other purposes.
CRS summary not yet available.
Referred to committee
Latest actionReferred to committee
This bill’s path
This is H.R. 3082’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed House
Passed Senate
Sent to President
Signed into law
- Sponsor
- Rep. Dina Titus (D-NV-1)
- Cosponsors
2 cosponsors
1 original · 1 later
- Rep. Ilhan Omar (D-MN-5)· Original · Apr 29, 2025
- Del. Eleanor Holmes Norton (D-DC)· Later · May 20, 2026
- Policy area
- Crime and Law Enforcement
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in House
Document: Introduced in House
Sources
- Congress.gov actionIntro-H
- Library of Congress
- Latest
Referred to committee
Referred to the Committee on Oversight and Government Reform, and in addition to the Committees on Energy and Commerce, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sources
- Congress.gov action
- House floor actions
Committees
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in House |
Titles (2)
Evidence-Based Drug Policy Act of 2025
Display title, Short title · Introduced in House
To repeal section 704(b)(12) of the Office of National Drug Control Policy Reauthorization Act of 1998, and for other purposes.
Official title · Introduced in House